Profilaxis de enfermedad tromboembólica en pacientes hospitalizados con patología médica, estrechando la brecha entre las guías y la práctica clínica
Thromboembolic disease is the main preventable cause of in-hospital death. Approximately 10% of nosocomial deaths are attributable to pulmonary embolism and in most cases, the diagnosis is not suspected before the autopsy. There are cost effective measures to decrease the incidence of thromboembolic...
Guardado en:
Autores principales: | Aizman,Andrés, Abbott,Eduardo, Rojas,Luis |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Médica de Santiago
2011
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872011000900016 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Rivaroxaban in acute venous thromboembolism: UK prescribing experience
por: Victoria Speed, et al.
Publicado: (2021) -
Patients with venous thromboembolism after spontaneous intracerebral hemorrhage: a review
por: Qiyan Cai, et al.
Publicado: (2021) -
PICO Questions and DELPHI Methodology for the Management of Venous Thromboembolism Associated with COVID-19
por: Antoni Riera-Mestre, et al.
Publicado: (2021) -
Venous Thromboembolism in COVID-19 Compared to Non-COVID-19 Cohorts: A Systematic Review with Meta-Analysis
por: Antonella Tufano, et al.
Publicado: (2021) -
Design and Baseline Data for a Prospective Observational Study of Rivaroxaban in Patients with Venous Thromboembolism in Japan (XASSENT)
por: Ikuo Fukuda, et al.
Publicado: (2021)